PHARMACEUTICAL COMPOSITION FOR TREATING HEPATITIS B VIRUS AND HEALTH FOOD PRODUCT HAVING HEPATITIS B VIRUS INHIBITING EFFECTS
    1.
    发明申请
    PHARMACEUTICAL COMPOSITION FOR TREATING HEPATITIS B VIRUS AND HEALTH FOOD PRODUCT HAVING HEPATITIS B VIRUS INHIBITING EFFECTS 审中-公开
    用于治疗乙型肝炎病毒和具有乙型肝炎病毒抑制作用的健康食品的药物组合物

    公开(公告)号:US20100168221A1

    公开(公告)日:2010-07-01

    申请号:US12648986

    申请日:2009-12-29

    IPC分类号: A61K31/352 A61P31/12

    摘要: The invention provides a pharmaceutical composition for treating hepatitis B, including: an effective amount of proanthocyanidins; and a pharmaceutically acceptable carrier or salt, wherein a formula of the monomer of the proanthocyanidins is shown in the following: , wherein R1 is OCH3, R2 is OH and R3 is H, or R1 is OH and R2 and R3 both are H, or R1 and R2 both are OH and R3 is H, or R1, R2 and R3 all are OH, and R4 is 3-(α)-OH, 3-(β)-OH, 3-(α)-O-sugar or 3-(β)-O-sugar. Bonding between adjacent monomers take place at C4, C8 Carbon-carbon bond or C2, C7 oxygen bond of A type or C4, C8 or C4, C6 Carbon-carbon bond of B type or C type of proanthocyanidins. And the polymerized number is from 2 to 30.

    摘要翻译: 本发明提供一种治疗乙型肝炎的药物组合物,包括:有效量的原花青素; 和其药学上可接受的载体或盐,其中原花青素单体的配方如下所示:其中R1是OCH3,R2是OH,R3是H,或R1是OH,R2和R3都是H,或 R1和R2都是OH,R3是H,或者R1,R2和R3都是OH,R4是3-(α)-OH,3-(α) - OH,3-(α)-O-糖 或3-(&bgr)) - O-糖。 相邻单体之间的键合发生在C4,C8碳 - 碳键或A型的C2,C7氧键或C4,C8或C4,C6B型或C型原花色素的碳 - 碳键。 聚合数为2〜30。

    Anthraquinone compound
    2.
    发明授权
    Anthraquinone compound 失效
    蒽醌化合物

    公开(公告)号:US06777564B2

    公开(公告)日:2004-08-17

    申请号:US10022411

    申请日:2001-12-20

    IPC分类号: C07D30734

    摘要: A novel compound with anthraquinone structure and having the following foluma (I): wherein R1, R2 and R3 each independently is hydrogen, hydroxy, amino or C1-6 alkyl group; R4 is hydrogen, C1-18 alkyl carbonyl, C1-6 alkyl group substituted by at least a functional group; R5 is hydrogen amino or a group of the following formula wherein R1, R2, R3 and R4 are defined as the above; and R and R′ each independently is hydrogen, hydroxyl, amino, C1-6 alkyl group or a group of the following formula wherein R1, R2, R3 and R4 are defined as the above.

    摘要翻译: 具有蒽醌结构的新化合物,具有以下组分(I):其中R 1,R 2和R 3各自独立地为氢,羟基,氨基或C 1-6烷基; R4是氢,C1-18烷基羰基,至少被官能团取代的C1-6烷基; R5是氢氨基或下列化学式的基团,R1,R2,R3和R4定义如上; 并且R和R'各自独立地为氢,羟基,氨基,C 1-6烷基或下列化学式的基团,R 1,R 2,R 3和R 4如上所定义。

    PREPARATION OF (S)-(+)-N-METHYL-3-(1-NAPHTHYLOXY)-3-(2-THIENYL) PROPYLAMINE USING OPTICALLY ACTIVE METHYLHYDROXYLAMINOPROPANOL DERIVATIVE AS AN INTERMEDIATE
    4.
    发明申请
    PREPARATION OF (S)-(+)-N-METHYL-3-(1-NAPHTHYLOXY)-3-(2-THIENYL) PROPYLAMINE USING OPTICALLY ACTIVE METHYLHYDROXYLAMINOPROPANOL DERIVATIVE AS AN INTERMEDIATE 有权
    使用光学活性甲基羟基氨基丙酰胺衍生物作为中间体制备(S) - (+) - N-甲基-3-(1-萘基)-3-(2-苯乙基)丙酰胺

    公开(公告)号:US20100234619A1

    公开(公告)日:2010-09-16

    申请号:US12402740

    申请日:2009-03-12

    IPC分类号: C07D333/20

    CPC分类号: C07D333/16

    摘要: The present invention provides a (S)-methylhydroxylaminopropanol derivative as an intermediate for preparation of (S)-(+)-N-methyl-3-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine. The present invention also provides a process for preparing (S)-(+)-N-methyl-3-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine with higher yield and lower cost, wherein the (S)-methylhydroxylaminopropanol derivative is used as an intermediate.

    摘要翻译: 本发明提供作为制备(S) - (+) - N-甲基-3-甲基-3-(1-萘氧基)-3-(2-噻吩基)丙胺的中间体的(S) - 甲基羟基氨基丙醇衍生物。 本发明还提供了以更高的产率和更低的成本制备(S) - (+) - N-甲基-3-甲基-3-(1-萘氧基)-3-(2-噻吩基)丙胺的方法,其中 (S) - 甲基羟基氨基丙醇衍生物用作中间体。

    METHYLHYDROXYLAMINOPROPANOL DERIVATIVE AND ITS USE AS INTERMEDIATE FOR PREPARATION OF 3-METHYLAMINO-1-(2-THIENYL)PROPAN-1-OL
    5.
    发明申请
    METHYLHYDROXYLAMINOPROPANOL DERIVATIVE AND ITS USE AS INTERMEDIATE FOR PREPARATION OF 3-METHYLAMINO-1-(2-THIENYL)PROPAN-1-OL 有权
    甲基甲硅烷基丙烯酸衍生物及其作为制备3-甲基氨基-1-(2-噻吩基)丙烷-1-醇的中间体

    公开(公告)号:US20090112000A1

    公开(公告)日:2009-04-30

    申请号:US11926772

    申请日:2007-10-29

    IPC分类号: C07D333/04

    CPC分类号: C07D333/20

    摘要: The present invention provides a methylhydroxylaminopropanol derivative and the methylhydroxylaminopropanol derivative of the present invention is used as an intermediate for preparation of 3-methylamino-1-(2-thienyl)propan-1-ol, which is an intermediate for preparation of (+)-(S)—N-methyl-3-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine oxalate. The present invention also provides a process for preparing 3-methylamino-1-(2-thienyl)propan-1-ol with higher yield and lower cost, wherein the methylhydroxylaminopropanol derivative is used as an intermediate.

    摘要翻译: 本发明提供甲基羟基氨基丙醇衍生物,本发明的甲基羟基氨基丙醇衍生物用作制备3-甲基氨基-1-(2-噻吩基)丙-1-醇的中间体,其是制备(+) - (S)-N-甲基-3-甲基-3-(1-萘氧基)-3-(2-噻吩基)丙胺草酸盐。 本发明还提供了一种制备3-甲基氨基-1-(2-噻吩基)丙-1-醇的方法,其中产率高,成本较低,其中甲基羟基氨基丙醇衍生物用作中间体。

    PROCESS FOR PREPARING N-METHYL-N-HYDROXYL-3-(1-NAPHTHYLOXY)-3-(2-THIENYL)PROPYLAMINE DERIVATIVE
    9.
    发明申请
    PROCESS FOR PREPARING N-METHYL-N-HYDROXYL-3-(1-NAPHTHYLOXY)-3-(2-THIENYL)PROPYLAMINE DERIVATIVE 有权
    制备N-甲基-N-羟基-3-(1-萘基)-3-(2-噻吩基)丙胺衍生物的方法

    公开(公告)号:US20100234620A1

    公开(公告)日:2010-09-16

    申请号:US12718289

    申请日:2010-03-05

    IPC分类号: C07D333/20

    CPC分类号: C07D333/16

    摘要: The present invention provides a process for preparing a N-methyl-N-hydroxyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine compound. The present invention also provides a process for preparing (S)-(+)-N-methyl-3-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine with higher yield and low treatment cost, which includes the preparation of the N-methyl-N-hydroxyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine compound.

    摘要翻译: 本发明提供了制备N-甲基-N-羟基-3-(1-萘氧基)-3-(2-噻吩基)丙胺化合物的方法。 本发明还提供了一种以高产率和低处理成本制备(S) - (+) - N-甲基-3-甲基-3-(1-萘氧基)-3-(2-噻吩基)丙胺的方法,其中 包括N-甲基-N-羟基-3-(1-萘氧基)-3-(2-噻吩基)丙胺化合物的制备。

    Synthetic methods and intermediates for steroisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders
    10.
    发明授权
    Synthetic methods and intermediates for steroisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders 有权
    用于治疗胃肠道和中枢神经系统疾病的立体异构化合物的合成方法和中间体

    公开(公告)号:US07629466B2

    公开(公告)日:2009-12-08

    申请号:US12109500

    申请日:2008-04-25

    IPC分类号: C07D453/02

    CPC分类号: C07D453/02 C07D211/58

    摘要: The subject invention provides methods and/or processes for making stereoisomeric compounds of formula (X): wherein the variables are as defined herein, and compositions for the safe and effective treatment of various gastrointestinal disorders including, but not limited to, gastroparesis, gastroesophageal reflux and related conditions. The compounds of the subject invention are also useful in treating a variety of conditions involving the central nervous system.

    摘要翻译: 本发明提供制备式(X)的立体异构体化合物的方法和/或方法:其中变量如本文所定义,以及用于安全和有效治疗各种胃肠道疾病的组合物,包括但不限于胃轻瘫,胃食管反流 和相关条件。 本发明的化合物还可用于治疗涉及中枢神经系统的多种病症。